The goal of this clinical trial is to evaluate the safety and effectiveness of the Polymotion Hip Resurfacing (PHR) System compared to total hip arthroplasty, for adults who require hip resurfacing arthroplasty due to 1) non-inflammatory arthritis (degenerative joint disease) such as osteoarthritis, traumatic arthritis, or 2) mild dysplasia/developmental dislocation of the hip (DDH) up to Crowe Grade 1.
The goal of this clinical trial is to evaluate the safety and effectiveness of the Polymotion Hip Resurfacing (PHR) System compared to total hip arthroplasty, for adults who require hip resurfacing arthroplasty due to 1) non-inflammatory arthritis (degenerative joint disease) such as osteoarthritis, traumatic arthritis, or 2) mild dysplasia/developmental dislocation of the hip (DDH) up to Crowe Grade 1.
Evaluate the Safety and Effectiveness of the Polymotion Hip Resurfacing (PHR) System Compared to Total Hip Arthroplasty
-
Florida Medical Clinic Orlando Health, Tampa, Florida, United States, 33613
Rush University Medical Center, Chicago, Illinois, United States, 60612
Sinai Hospital / LifeBridge Health, Baltimore, Maryland, United States, 21215
NYU Longone, New York, New York, United States, 10003
Joint Implant Surgeons, New Albany, Ohio, United States, 43054
Midlands Orthopaedics & Neurosurgery, Columbia, South Carolina, United States, 29210
Hampton Road Orthopaedics, Newport News, Virginia, United States, 23606
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
21 Years to 65 Years
ALL
No
JointMedica Inc.,
Michael Mont, MD, PRINCIPAL_INVESTIGATOR, Principal Investigator
2028-01